Literature DB >> 17050004

Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations.

Thomas Vogl1, Nadja Leukert, Katarzyna Barczyk, Kerstin Strupat, Johannes Roth.   

Abstract

S100A8 and S100A9 are two proinflammatory molecules belonging to the S100 family of calcium-binding proteins. Common to all S100 proteins S100A8 and S100A9 form non-covalently associated complexes which have been shown to exhibit different functional properties. Besides dimerization, recent research is focused on the importance of higher oligomeric structures of S100 proteins induced by bivalent cations. While S100A8/S100A9-heterodimers are formed in the absence of calcium, tetramerization is strictly calcium-dependent. Heterodimer formation is not a simple process and our biophysical analyses (FRET, ESI-MS) demonstrate that simply mixing both subunits is not sufficient to induce complex formation. Steps of denaturation/renaturation are necessary for the recombinant complex to show identical biophysical properties as S100A8/S100A9 obtained from granulocytes. In addition to calcium both proteins are able to bind zinc with high affinity. Here we demonstrate for the first time by different biophysical methods (MALDI-MS, ESI-MS, fluorescence spectroscopy) that zinc-binding, like calcium, induces (S100A8/S100A9)(2)-tetramers. Using mass spectrometric investigations we demonstrate that zinc triggers the formation of (S100A8/S100A9)(2)-tetramers by zinc-specific binding sites rather than by interactions with calcium-specific EF-hands. The zinc-induced tetramer is structurally very similar to the calcium-induced tetramer. Thus, like calcium, zinc acts as a regulatory factor in S100A8/S100A9-dependent signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050004     DOI: 10.1016/j.bbamcr.2006.08.028

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  62 in total

Review 1.  Binding of transition metals to S100 proteins.

Authors:  Benjamin A Gilston; Eric P Skaar; Walter J Chazin
Journal:  Sci China Life Sci       Date:  2016-07-19       Impact factor: 6.038

2.  Initial Biochemical and Functional Evaluation of Murine Calprotectin Reveals Ca(II)-Dependence and Its Ability to Chelate Multiple Nutrient Transition Metal Ions.

Authors:  Rose C Hadley; Yu Gu; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2018-05-02       Impact factor: 3.162

3.  Relating form and function of EF-hand calcium binding proteins.

Authors:  Walter J Chazin
Journal:  Acc Chem Res       Date:  2011-02-11       Impact factor: 22.384

4.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

5.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

6.  Calprotectin Pegylation Enhanced Its Physical and Structural Properties.

Authors:  Abbas Shahsavari; Mehdi Azad; Naser Mobarra; Koorosh Goodarzvand Chegini; Nematollah Gheibi
Journal:  Protein J       Date:  2016-10       Impact factor: 2.371

7.  Metal Sequestration and Antimicrobial Activity of Human Calprotectin Are pH-Dependent.

Authors:  Tomer Rosen; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2020-06-22       Impact factor: 3.162

8.  Modulation of quaternary structure of S100 proteins by calcium ions.

Authors:  Werner W Streicher; Maria M Lopez; George I Makhatadze
Journal:  Biophys Chem       Date:  2010-06-23       Impact factor: 2.352

9.  Zn2+ binding to human calbindin D(28k) and the role of histidine residues.

Authors:  Mikael C Bauer; Hanna Nilsson; Eva Thulin; Birgitta Frohm; Johan Malm; Sara Linse
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

10.  S100A8 and S100A9 in experimental osteoarthritis.

Authors:  Hala Zreiqat; Daniele Belluoccio; Margaret M Smith; Richard Wilson; Lynn A Rowley; Katie Jones; Yogambha Ramaswamy; Thomas Vogl; Johannes Roth; John F Bateman; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2010-01-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.